A Study of Bispecific Antibody QLS31901 in Patients With Advanced or Metastatic Malignancies

NCT04954456 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Malignant Tumor

Interventions

DRUG: QLS31901

Sponsor

Qilu Pharmaceutical Co., Ltd.